Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

Branding experts weigh in on Vistara's sky-high standards in delivering consumer experience, which built its reputation as a uniquely Indian luxury brand ...

Gilead Sciences, Inc. today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is studying twice-yearly lenacapavir, the company's ...

Nestled in the heart of Warren, Ohio, there’s a hidden gem that’s been rocking the local art scene since 2009. David Grohl Alley isn’t your average back street – it’s a colorful tribute to one of rock ...

Trailblazers like Nathalie Verdeille and Claire Choisne are redefining timeless jewellery with fresh perspectives and ...

Starting on Nov. 15, 2024, X will use everything you post to train its AI. Here's how to deactivate your X account.

Therapeuticsmd Inc ( (TXMD) ) has released its Q3 earnings. Here is a breakdown of the information Therapeuticsmd Inc presented to its ...

It’s a jungle out there. Deriving the right royalty rate for new pharmaceuticals and biotechnologies is a real tangle. This is a critical business function, and it has never been more important ...

Aug. 21, 2024 at 12:16 p.m. ET on GuruFocus.com ...

The growth of the Oilfield Stimulation Chemicals Market is driven by several key factors. The increasing demand for enhanced oil recovery techniques and the need to maximize production from mature ...

Despite discontinuing the original Steam Link hardware a few years ago, Valve is still interested in refining and updating ...

Source: The College Investor If you're looking for passive income ideas, you may think the whole concept is a myth - there's ...